Literature DB >> 34755831

Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.

Lauren Pickel1, Ioan-Andrei Iliuta2, James Scholey2,3, York Pei2, Hoon-Ki Sung1,4.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the progressive growth of renal cysts, leading to the loss of functional nephrons. Recommendations for individuals with ADPKD to maintain a healthy diet and lifestyle are largely similar to those for the general population. However, recent evidence from preclinical models suggests that more tightly specified dietary regimens including caloric restriction, intermittent fasting, and ketogenic diets hold promise to slow disease progression, and the results of ongoing human clinical trials are eagerly awaited. These dietary interventions directly influence nutrient signalling and substrate availability in the cystic kidney, while also conferring systemic metabolic benefits. The present review focuses on the importance of local and systemic metabolism in ADPKD and summarizes current evidence for dietary interventions to slow disease progression and improve quality of life.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  ADPKD; beta-hydroxybutyrate; diet; fasting; hereditary kidney disease; ketosis; polycystic kidney; slow progression; time-restricted eating; time-restricted feeding

Year:  2021        PMID: 34755831      PMCID: PMC8970828          DOI: 10.1093/advances/nmab131

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  193 in total

Review 1.  History of the ketogenic diet.

Authors:  James W Wheless
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

2.  Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).

Authors:  Anna S Nikonova; Alexander Y Deneka; Anna A Kiseleva; Vladislav Korobeynikov; Anna Gaponova; Ilya G Serebriiskii; Meghan C Kopp; Harvey H Hensley; Tamina N Seeger-Nukpezah; Stefan Somlo; David A Proia; Erica A Golemis
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

3.  Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat.

Authors:  Naser H M Ibrahim; Yong Jia; Jessay G Devassy; Tamio Yamaguchi; Harold M Aukema
Journal:  Mol Nutr Food Res       Date:  2013-10-30       Impact factor: 5.914

4.  Are Cyst-Associated Macrophages in Polycystic Kidney Disease the Equivalent to TAMs in Cancer?

Authors:  Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2018-09-12       Impact factor: 10.121

Review 5.  β-Hydroxybutyrate: A Signaling Metabolite.

Authors:  John C Newman; Eric Verdin
Journal:  Annu Rev Nutr       Date:  2017-08-21       Impact factor: 11.848

6.  Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.

Authors:  Li Chen; Xia Zhou; Lucy X Fan; Ying Yao; Katherine I Swenson-Fields; Mihaela Gadjeva; Darren P Wallace; Dorien J M Peters; Alan Yu; Jared J Grantham; Xiaogang Li
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

7.  Association of kidney and cysts dimensions with anthropometric and biochemical parameters in patients with ADPKD.

Authors:  Maria Pietrzak-Nowacka; Krzysztof Safranow; Janina Palacz; Edyta Gołembiewska; Małgorzata Marchelek-Myśliwiec; Kazimierz Ciechanowski
Journal:  Ren Fail       Date:  2015-04-14       Impact factor: 2.606

8.  Lipid Peroxidation Drives Renal Cyst Growth In Vitro through Activation of TMEM16A.

Authors:  Rainer Schreiber; Björn Buchholz; Andre Kraus; Gunnar Schley; Julia Scholz; Jiraporn Ousingsawat; Karl Kunzelmann
Journal:  J Am Soc Nephrol       Date:  2019-01-03       Impact factor: 10.121

9.  Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats.

Authors:  Denise E Fair; Malcolm R Ogborn; Hope A Weiler; Neda Bankovic-Calic; Evan P Nitschmann; Shirley C Fitzpatrick-Wong; Harold M Aukema
Journal:  J Nutr       Date:  2004-06       Impact factor: 4.798

10.  Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children.

Authors:  Peter O Kwiterovich; Eileen P G Vining; Paula Pyzik; Richard Skolasky; John M Freeman
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

View more
  3 in total

1.  The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life.

Authors:  Ola Tarabzuni
Journal:  Cureus       Date:  2022-05-16

2.  Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cortney Steele; Kristen Nowak
Journal:  Kidney Dial       Date:  2022-03-04

Review 3.  Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease.

Authors:  Ioan-Andrei Iliuta; Xuewen Song; Lauren Pickel; Amirreza Haghighi; Ravi Retnakaran; James Scholey; Hoon-Ki Sung; Gregory R Steinberg; York Pei
Journal:  Front Mol Biosci       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.